Clinical Trial Update: Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

View source ↗

Summary

Completed clinical trial investigating cases of serious infections due to carbapenem-resistant Enterobacteriaceae across multiple infection types.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia
• Pyelonephritis
• Ventilator-associated Pneumonia

Snippet

Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | Conditions: Urinary Tract Infection, Complicated, Acute Pyelonephritis | Status: COMPLETED